Peri-operative SARS-CoV-2 infection increases postoperative mortality. The aim of this study was to determine the optimal duration of planned delay before surgery in patients who have had SARS-CoV-2 infection. This international, multicentre, prospective cohort study included patients undergoing elective or emergency surgery during October 2020. Surgical patients with pre-operative SARS-CoV-2 infection were compared with those without previous SARS-CoV-2 infection. The primary outcome measure was 30-day postoperative mortality. Logistic regression models were used to calculate adjusted 30-day mortality rates stratified by time from diagnosis of SARS-CoV-2 infection to surgery. Among 140,231 patients (116 countries), 3127 patients (2.2%) had a pre-operative SARS-CoV-2 diagnosis. Adjusted 30-day mortality in patients without SARS-CoV-2 infection was 1.5% (95%CI 1.4-1.5). In patients with a pre-operative SARS-CoV-2 diagnosis, mortality was increased in patients having surgery within 0-2 weeks, 3-4 weeks and 5-6 weeks of the diagnosis (odds ratio (95%CI) 4.1 (3.3-4.8), 3.9 (2.6-5.1) and 3.6 (2.0-5.2), respectively). Surgery performed ≥ 7 weeks after SARS-CoV-2 diagnosis was associated with a similar mortality risk to baseline (odds ratio (95%CI) 1.5 (0.9-2.1)). After a ≥ 7 week delay in undertaking surgery following SARS-CoV-2 infection, patients with ongoing symptoms had a higher mortality than patients whose symptoms had resolved or who had been asymptomatic (6.0% (95%CI 3.2-8.7) vs. 2.4% (95%CI 1.4-3.4) vs. 1.3% (95%CI 0.6-2.0), respectively). Where possible, surgery should be delayed for at least 7 weeks following SARS-CoV-2 infection. Patients with ongoing symptoms ≥ 7 weeks from diagnosis may benefit from further delay.
The delay in surgical resection necessary to complete preoperative radiation does not seem to increase the risk of lethal metastatic spread. The risk of local recurrence may be lower after preoperative radiation. These findings must be interpreted with caution because of the heterogeneity and bias in the available studies.
SARS-CoV-2 has been associated with an increased rate of venous thromboembolism in critically ill patients. Since surgical patients are already at higher risk of venous thromboembolism than general populations, this study aimed to determine if patients with peri-operative or prior SARS-CoV-2 were at further increased risk of venous thromboembolism. We conducted a planned sub-study and analysis from an international, multicentre, prospective cohort study of elective and emergency patients undergoing surgery during October 2020. Patients from all surgical specialties were included. The primary outcome measure was venous thromboembolism (pulmonary embolism or deep vein thrombosis) within 30 days of surgery. SARS-CoV-2 diagnosis was defined as peri-operative (7 days before to 30 days after surgery); recent (1-6 weeks before surgery); previous (≥7 weeks before surgery); or none. Information on prophylaxis regimens or pre-operative anti-coagulation for baseline comorbidities was not available. Postoperative venous thromboembolism rate was 0.5% (666/123,591) in patients without SARS-CoV-2; 2.2% (50/2317) in patients with peri-operative SARS-CoV-2; 1.6% (15/953) in patients with recent SARS-CoV-2; and 1.0% (11/1148) in patients with previous SARS-CoV-2. After adjustment for confounding factors, patients with peri-operative (adjusted odds ratio 1.5 (95%CI 1.1-2.0)) and recent SARS-CoV-2 (1.9 (95%CI 1.2-3.3)) remained at higher risk of venous thromboembolism, with a borderline finding in previous SARS-CoV-2 (1.7 (95%CI 0.9-3.0)). Overall, venous thromboembolism was independently associated with 30-day mortality ). In patients with SARS-CoV-2, mortality without venous thromboembolism was 7.4% (319/4342) and with venous thromboembolism was 40.8% (31/76). Patients undergoing surgery with peri-operative or recent SARS-CoV-2 appear to be at increased risk of postoperative venous thromboembolism compared with patients with no history of SARS-CoV-2 infection. Optimal venous thromboembolism prophylaxis and treatment are unknown in this cohort of patients, and these data should be interpreted accordingly.
The coronavirus disease 2019 (COVID-19) pandemic presented a significant challenge to health-care systems globally. The Saudi government took rapid and unprecedented precautionary measures to limit this disease's explosive spread. [1,2] Nevertheless, severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) had infected almost 360,000 patients in Saudi Arabia by early December 2020. [3] This, in turn, jeopardized the ability of the health-care service to provide the required medical care for COVID-19 and non-COVID-19 patients. Cancer patients are more susceptible to infection than individuals without cancer because of the systemic immunosuppressive
Rotating hinged knee replacements are used to restore knee stability when intrinsic stability is lost in the form of soft tissue compression. With medical engineering advancements and improvements in arthroplasty, intrinsic stability can be achieved by an implant post system. We present the case of a 44-yearold female who presented with post-traumatic right knee multi-ligamentous instability and advanced secondary osteoarthritis following a traumatic knee dislocation two years ago. The patient initially underwent a hinged total knee replacement. After five years, she got dislocation of hinged total knee replacement that affected her condition and necessitated emergency admission for open reduction and revision. Most reported cases of rotating hinge prosthesis dislocation occurred during the first year of follow-up. However, our case dislocated after five years of follow-up due to dislodgement from the tibial tray with the polyethylene channel in the form of fatigue failure of the anti-dislocation mechanism.
There are numerous conditions that arise from the surface of bones including both neoplastic and non-neoplastic entities. Schwannoma had been reported to be one of those conditions originating from the bone surface with variable proposed theories on it’s origin. We present a unique case of subperiosteal schwannoma arising from the humerus in a 40 years old female with history of painful swelling for two years. Radiograph showed cortically based lytic lesion located in the lateral distal humeral metaphysis with periosteal reaction and cortical scalloping. MRI showed the same juxtacortical lesion with a large extraosseous soft tissue component. It demonstrates intermediate T1 signal intensity and high signal intensity on T2 weighted images with intense enhancement. US guided biopsy showed benign peripheral nerve sheath tumour, consistent with schwannoma. The patient underwent complete rescetion with no complications or documented recurrence till the latest follow-up. In conclusion, subperiosteal schwannoma should be kept in the differential diagnosis in patients presenting with bone surface lesions associated with unexplained vague pain and swelling for a prolonged period of time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.